(Q40867776)

24 September 2017

1 reference

title

Immunological requirements for a subunit vaccine against tuberculosis (English)

1 reference

24 September 2017

1 reference

Elhay MJ

1

1 reference

24 September 2017

Andersen P

series ordinal

2

1 reference

24 September 2017

publication date

1 December 1997

1 reference

Immunology & Cell Biology

24 September 2017

published in

1 reference

24 September 2017

volume

75

1 reference

24 September 2017

issue

6

1 reference

24 September 2017

page(s)

595-603

1 reference

https://scigraph.springernature.com/pub.10.1038/icb.1997.94

24 September 2017

exact match

0 references

cites work

Variation in protection by BCG: implications of and for heterologous immunity

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Efficacy of BCG vaccine against leprosy and tuberculosis in northern Malawi

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Progression of human immunodeficiency virus infection in patients with tuberculosis disease. A cohort study in Bordeaux, France, 1988-1994. The Groupe d'Epidémiologie Clinique du Sida en Aquitaine (GECSA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

T cell response to Mycobacterium tuberculosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Disseminated tuberculosis in interferon gamma gene-disrupted mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Specific lysis of mycobacterial antigen-bearing macrophages by class II MHC-restricted polyclonal T cell lines in healthy donors or patients with tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

The protective immune response to Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

The relationship of delayed hypersensitivity to acquired cellular resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Immunization of mice with mycobacterial culture filtrate proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Protective immunity against tuberculosis induced by vaccination with major extracellular proteins of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Identification of immunodominant antigens during infection with Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Identification of macrophage and stress-induced proteins of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

MPB 64 Possesses Tuberculosis-Complex'-Specific B- and T-Cell Epitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

The T cell response to secreted antigens of Mycobacterium tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Vaccination against tuberculosis by DNA injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

The 14,000-molecular-weight antigen of Mycobacterium tuberculosis is related to the alpha-crystallin family of low-molecular-weight heat shock proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

A mycobacterial extracytoplasmic function sigma factor involved in survival following stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Immune response to chemically modified flagellin. 3. Enhanced cell-mediated immunity during high and low zone antibody tolerance to flagellin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

A strategy to improve the efficacy of vaccination against tuberculosis and leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Adjuvants: current status, clinical perspectives and future prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Immunological adjuvants: a role for liposomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Heterologous protection against influenza by injection of DNA encoding a viral protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

Species level identification of non-tuberculous mycobacteria from South Indian BCG trial area during 1981

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Isolation and Identification of Environmental Mycobacteria in the Mycobacterium bovis BCG Trial Area of South India.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

How environmental mycobacteria may predetermine the protective efficacy of BCG

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Bacille Calmette-Guérin adenitis 30 years after immunization in a patient with AIDS

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Secreted Antigens of Mycobacterium tuberculosis: Characterization with T Lymphocytes from Patients and Contacts after Two-Dimensional Separation

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Induction of cytotoxic T-cell responses against culture filtrate antigens in Mycobacterium bovis bacillus Calmette-Guérin-infected mice

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Effective vaccination of mice against Mycobacterium tuberculosis infection with a soluble mixture of secreted mycobacterial proteins

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Immunization with extracellular proteins of Mycobacterium tuberculosis induces cell-mediated immune responses and substantial protective immunity in a guinea pig model of pulmonary tuberculosis

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Proteins released from Mycobacterium tuberculosis during growth.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Induction of mycobacterial proteins during phagocytosis and heat shock: a time interval analysis.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Modulation of expression of delayed hypersensitivity by mycobacterial antigen 85 fibronectin-binding proteins

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Immunogenicity and toxicity testing of an experimental HIV-1 vaccine in nonhuman primates

1 reference

https://api.crossref.org/works/10.1038%2FICB.1997.94

7 January 2021

Identifiers

DOI

10.1038/ICB.1997.94

1 reference

Dimensions Publication ID

24 September 2017

1031026045

0 references

Fatcat ID

release_jrkpy6kxtvhzjg7ll27tuhmst4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jrkpy6kxtvhzjg7ll27tuhmst4

24 November 2022

mapped directly with Wikidata item

1 reference